Amplify Weight Loss Drug & Treatment ETF
THNR
4 hedge funds and large institutions have $1.39M invested in Amplify Weight Loss Drug & Treatment ETF in 2025 Q1 according to their latest regulatory filings, with funds opening new positions, 3 increasing their positions, 1 reducing their positions, and closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
10% more capital invested
Capital invested by funds: $1.26M → $1.39M (+$130K)
4.82% more ownership
Funds ownership: 31.04% → 35.86% (+4.8%)
0% more funds holding
Funds holding: 4 → 4 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GS
GTS Securities
New York
|
+$194K |
| 2 |
Jane Street
New York
|
+$27.6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$3.46K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HI
Harbour Investments
Madison,
Wisconsin
|
-$27.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GS
1
GTS Securities
New York
| $719K | +$194K | +8,506 | +34% |
|
|
2
Jane Street
New York
| $536K | +$27.6K | +1,215 | +5% |
|
|
HI
3
Harbour Investments
Madison,
Wisconsin
| $123K | -$27.3K | -1,200 | -17% |
|
|
4
UBS Group
Zurich,
Switzerland
| $12.9K | +$3.46K | +152 | +34% |
|
THNR Hedge Fund Activity: Q1 2025 in Review
4 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Amplify Weight Loss Drug & Treatment ETF (THNR) for Q1 2025, worth a combined $1.39M — up 10% from $1.26M a quarter earlier.
Fund positioning in THNR was balanced in Q1 2025: 0 funds opened new positions, 0 closed out, 3 added to existing stakes and 1 trimmed.
The largest buyer was GTS Securities, adding an estimated $194K. The largest seller was Harbour Investments, cutting an estimated $27.3K.
- 4 institutional investors held Amplify Weight Loss Drug & Treatment ETF (THNR) as of Q1 2025, unchanged from Q4 2024.
- Funds reported $1.39M of Amplify Weight Loss Drug & Treatment ETF stock for Q1 2025, up 10% quarter-over-quarter.
- 0 funds opened new Amplify Weight Loss Drug & Treatment ETF positions in Q1 2025 and 0 closed out.
- The largest Amplify Weight Loss Drug & Treatment ETF buyer in Q1 2025 was GTS Securities, an estimated $194K added.
- The largest Amplify Weight Loss Drug & Treatment ETF seller in Q1 2025 was Harbour Investments, an estimated $27.3K sold.
Based on aggregated 13F filings for Q1 2025.